Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $177.27 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $58.28 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $36.72 | 2 | $0 (2022) |
| Johnson & Johnson Surgical Vision, Inc. | $23.48 | 1 | $0 (2022) |
| Oyster Point Pharma, Inc. | $18.12 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $16.07 | 1 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $15.36 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.36 | 1 | Tarsus Pharmaceuticals, Inc. ($15.36) |
| 2023 | $34.19 | 2 | Oyster Point Pharma, Inc. ($18.12) |
| 2022 | $38.23 | 2 | Johnson & Johnson Surgical Vision, Inc. ($23.48) |
| 2020 | $21.97 | 1 | Novartis Pharmaceuticals Corporation ($21.97) |
| 2018 | $67.52 | 2 | Allergan Inc. ($58.28) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: DRY EYE | ||||||
| 08/11/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2022 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device), Tecnis IOL, TECNIS IOL | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Optics | ||||||
| 01/05/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/29/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/12/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $58.28 | General |
| Category: RETINA | ||||||
| 03/19/2018 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $9.24 | General |
| Category: Medical Device (510K) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 401 | 451 | $49,047 | $23,291 |
| 2022 | 8 | 386 | 437 | $49,616 | $24,869 |
| 2021 | 9 | 390 | 441 | $49,524 | $24,099 |
| 2020 | 9 | 449 | 516 | $61,214 | $25,575 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 128 | $17,792 | $9,782 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 96 | $9,024 | $5,595 | 62.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 30 | 35 | $3,955 | $2,205 | 55.8% |
| 92134 | Imaging of retina | Office | 2023 | 79 | 81 | $6,561 | $1,924 | 29.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 33 | 36 | $4,212 | $1,324 | 31.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 43 | 58 | $4,698 | $1,234 | 26.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 16 | 17 | $2,805 | $1,226 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 119 | $16,541 | $9,733 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 85 | $7,990 | $4,916 | 61.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 41 | 55 | $6,215 | $3,391 | 54.6% |
| 92134 | Imaging of retina | Office | 2022 | 61 | 65 | $5,265 | $1,832 | 34.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 21 | 21 | $3,465 | $1,645 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,652 | $1,196 | 45.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 42 | 52 | $4,212 | $1,176 | 27.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 28 | 28 | $3,276 | $980.47 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 108 | $15,012 | $9,053 | 60.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 116 | $10,904 | $6,676 | 61.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 60 | 67 | $5,427 | $1,883 | 34.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 19 | 22 | $2,486 | $1,467 | 59.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 22 | 23 | $3,795 | $1,429 | 37.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 48 | 58 | $4,698 | $1,155 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,652 | $992.16 | 37.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 21 | 22 | $2,574 | $733.05 | 28.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,976 | $708.88 | 35.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 117 | 132 | $21,716 | $9,785 | 45.1% |
About Dr. Correen Hayes, O.D
Dr. Correen Hayes, O.D is a Optometrist healthcare provider based in Fremont, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508818113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Correen Hayes, O.D has received a total of $177.27 in payments from pharmaceutical and medical device companies, with $15.36 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($177.27).
As a Medicare-enrolled provider, Hayes has provided services to 1,626 Medicare beneficiaries, totaling 1,845 services with total Medicare billing of $97,833. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Fremont, MI
- Active Since 05/16/2006
- Last Updated 10/29/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1508818113
Products in Payments
- OZURDEX (Drug) $58.28
- XIIDRA (Drug) $36.72
- Tecnis IOL (Device) $23.48
- TYRVAYA (Drug) $18.12
- EYLEA (Biological) $16.07
- XDEMVY (Drug) $15.36
- Prokera (Device) $9.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Fremont
Abby Hsu, O.d, O.D
Optometrist — Payments: $18,390
Jenny Tseng, O. D, O. D
Optometrist — Payments: $8,313
Dr. Kimberly Haw, O.d, O.D
Optometrist — Payments: $5,769
Dr. Sara Chiu, O.d, O.D
Optometrist — Payments: $5,742
Brian Gin, O.d, O.D
Optometrist — Payments: $5,080
Dr. Corwin Li, O.d, O.D
Optometrist — Payments: $4,305